FDA Food and Drug Administration

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA Approves the First Non-Opioid Pain Drug in 20 Years

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.

CNN on MSN · 7h

FDA approves first new type of pain medication in 25 years

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

WXIN-TV Indianapolis on MSN · 1h

FDA approves new type of non-opioid pain medication

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is

FDA, Axsome and migraine

Hosted on MSN · 12h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday. The oral drug, branded Symbravo, was approved for the acute treatment of the condition characterized by recurrent attacks of moderate to severe throbbing and pulsating pain on one side of the head.

Business Insider · 15h

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Investing.com on MSN · 14h

FDA approves new migraine treatment SYMBRAVO

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,

MLive11h

This chocolate recall has been upgraded to FDA’s highest risk level

STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...

20hon MSNOpinion

The FDA’s new, same-old food labels demand better obesity solutions

All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

WISH-TV on MSN13h

FDA redefines ‘healthy’ food labels to help consumers make informed choices

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...

STAT2h

With little fanfare, Biden administration stacked vaccine advisory committee with new members

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

NVS Earnings: Entresto Drugmaker Novartis Tops Estimates as Patent Expiry Looms

Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...

Opinion

3hOpinion

Comment: Senators, immunize against RFK Jr.’s vaccine hypocrisy

Kennedy has tried to recast his anti-vaccine extremism as an honest effort to illuminate what he claims is unsettled science (it’s not). He insists he’s not trying to take away anyone’s shots; he’s ...

STAT2h

How to protect HHS, FDA, NIH, and other health agencies from political interference

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

Feeling sick? Here’s what to take and what to avoid, according to a doctor

CNN wellness expert Dr. Leana Wen suggests what to do to reduce your risk of catching respiratory viruses this winter and how to treat them if you’re sick.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results